BCSI‘s solutions build on two core technology platforms: non-invasive fluoroscopic evaluation micro-fluidic genetic materials solutions.
Both solutions have one clear goal: To create value for all stakeholders (patients, clinicians, collaborators, and shareholders) by leveraging our fluorescent dye, micro-fluidics, and nucleic acid extraction capabilities and Intellectual Property to reduce healthcare costs AND improve patient outcomes.
The Fluoroscopic Evaluation family of products are based on patented, optical fluorescent technology. The measurement devices are used in combination with disposables to accurately and reliably measure the pH of fluids such as platelets, the media used in IVF and other culture media.
The Simple Nucleic Acid Processing (SNAP) family of products are built using our proprietary flat glass extraction technology. Capable of quickly, efficiently, and reliably isolating nucleic acids (DNA and RNA) from blood and a variety of other biological specimens, SNAP can help improve extraction in your lab.
